Technology | Clinical Decision Support | March 10, 2016

Wanda, Dignity Health Launch OncoVerse Oncology Decision Support

Software provides oncologists and cancer patients with decision support and collaboration capabilities using Wanda's digital health platform

March 10, 2016 — Wanda Inc., in partnership with Dignity Health, announced the launch of the OncoVerse virtual care collaboration platform. OncoVerse is a digital health platform designed to enable the patient's care team to collaborate in real time and allow clinicians across all disciplines to work together to determine the most effective treatment plan for cancer patients.

OncoVerse was initially conceived by a Dignity Health physician who wanted a tool to improve team collaboration, especially when evaluating a complex cancer case and determining the appropriate treatment plan. Dignity Health engaged Wanda to develop the software due to the company's proven track record to support informed treatment decisions, and to reduce administrative costs.

OncoVerse enables information-sharing capabilities through geographically dispersed, structured collaboration of the multidisciplinary care team in real time. Dignity Health can now expand the reach of its best available clinical decision-making support through OncoVerse to rural and remote areas, enabling patients in those locations to benefit from insights previously only shared at large medical centers. 

Wanda and Dignity Health intend to jointly market the Oncoverse platform available to other oncology programs across the United States later in 2016.

For more information: www.yourwanda.com

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
LVivo EF Cardiac Tool Now Available for GE Vscan Extend Handheld Mobile Ultrasound
Technology | Cardiovascular Ultrasound | September 19, 2018
DiA Imaging Analysis Ltd. (DiA), a provider of artificial intelligence (AI)-powered ultrasound analysis tools,...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...